Matinas BioPharma to combine with GH Power, forming new public parent GH Power International

Matinas BioPharma announced a reorganization via a business combination with GH Power to form Ontario-based GH Power International as the new public parent.

• The transaction targets a NYSE American listing for the combined clean energy and critical materials company, with closing expected in Q4 2026.
• GH Power holders are expected to own about 91% post-close, while Matinas holders are expected to own about 9% on a fully diluted basis.
• Each Matinas common share is expected to convert into 0.1 of a GH Power International common share.
• Options and warrants are expected to roll over.
• Closing conditions include at least $15 million in PIPE financing, shareholder approvals, Ontario court approvals and Form F-4 effectiveness.